CTNNB1 and neoplasm: The p.G34E and p.T41I missense mutations accounted for around 41% of all Ctnnb1 mutations; tumours with p.G34E mutations also had a higher overall mutation burden compared with tumours with other exon-3 mutations (Supplementary Fig. 2f–h).